Family Medicine
Study: Some Social Distance May Need to Continue Until 2022
15 Apr, 2020 | 03:47h | UTCProjecting the transmission dynamics of SARS-CoV-2 through the postpandemic period – Science
Commentaries: Coronavirus distancing may need to continue until 2022, say experts – The Guardian AND Harvard Researchers Say Some Social Distancing May Be Needed Into 2022 – Bloomberg AND Researchers Say Social Distancing To Prevent Coronavirus May Need To Continue Until 2022 – Forbes AND Some social distancing may be needed into 2022 to keep coronavirus in check, new study says – STAT
Related Commentary on Twitter
They had me at "Prolonged or intermittent social distancing may be necessary into 2022." An important new @Sciencemagazine paper on what to expect in the #COVID19 "post pandemic" periodhttps://t.co/x1KlVanIxo @mlipsitch @yhgrad @StephenKissler and colleagues @HarvardChanSPH pic.twitter.com/mq2QIWvfgk
— Eric Topol (@EricTopol) April 14, 2020
New ATS Guideline: Pharmacologic Management of COPD
15 Apr, 2020 | 03:49h | UTCCommentary: New COPD Guidelines Issued – NEJM Journal Watch
Ending Coronavirus Lockdowns Will be a Dangerous Process of Trial and Error
15 Apr, 2020 | 03:45h | UTCEnding coronavirus lockdowns will be a dangerous process of trial and error – Science
Related: ‘Suppress and lift’: Hong Kong and Singapore say they have a coronavirus strategy that works – Science AND Opinions on Lifting Coronavirus Pandemic Lockdowns (opinions and report) AND Scott Gottlieb on how, and when, to end social distancing – Vox
Hydroxychloroquine for Covid-19: No Benefit in New Open-label, Randomized Trial
15 Apr, 2020 | 03:42h | UTC[Preprint] Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial – medRxiv
See also just published observational study (Preprint): No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial – medRxiv
Related Commentary on Twitter
#COVID19 Here comes another dataset of #Hydroxychloroquine from an open-label randomized controlled trial in Chinahttps://t.co/qW93wMDILK
No difference in 28-day #coronavirus negative conversion rate for HCQ + SOC vs SOC
No difference in 28-day symptoms alleviation rate either pic.twitter.com/pOsBSQWeuO
— Andy Biotech (@AndyBiotech) April 14, 2020
FDA Issues Emergency Use Authorization to Decontaminate Millions of N95 Respirators
15 Apr, 2020 | 03:38h | UTCCommentary: FDA clears N95 decontamination process that could clean up to 4 million masks per day – Tech Crunch
CEBM Oxford COVID-19 Evidence Updates:
15 Apr, 2020 | 03:32h | UTC“Current data do not support the use of hydroxychloroquine for prophylaxis or treatment of COVID-19.”
- How can pandemic spreads be contained in care homes?
- Editor’s commentary: Rapid reviews of PPE – an update
- “When will it be over?”: An introduction to viral reproduction numbers, R0 and Re
Study: Alcohol-based Hand Rub Solutions are Effective for Virus Inactivation
15 Apr, 2020 | 03:26h | UTCCommentary: Studies: Hand sanitizers kill COVID-19 virus, e-consults appropriate – CIDRAP
Perspective: Virtual Health Care in the Era of COVID-19
15 Apr, 2020 | 03:18h | UTCVirtual health care in the era of COVID-19 – The Lancet
Related: Rapidly Converting to “Virtual Practices”: Outpatient Care in the Era of Covid-19 (several texts on the subject)
Review: Diagnosis and Management of Obstructive Sleep Apnea
15 Apr, 2020 | 03:14h | UTCDiagnosis and Management of Obstructive Sleep Apnea: A Review – JAMA (free for a limited period)
Review: Diagnostic Testing for SARS-CoV-2
14 Apr, 2020 | 03:06h | UTC
Review: Pharmacologic Treatments for COVID-19
14 Apr, 2020 | 03:05h | UTCPharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review – JAMA
Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
14 Apr, 2020 | 03:02h | UTCUniversal Screening for SARS-CoV-2 in Women Admitted for Delivery – New England Journal of Medicine
Commentary: Universal Screening for SARS-CoV-2 at Delivery Could Identify Many Asymptomatic Women – NEJM Journal Watch
“29 of the 33 patients who were positive for SARS-CoV-2 at admission (87.9%) had no symptoms of Covid-19 at presentation”
Ethics in the Time of Coronavirus: Recommendations in the COVID-19 Pandemic
14 Apr, 2020 | 03:00h | UTC
Commentary on the New IDSA’s COVID-19 Treatment Guidelines
14 Apr, 2020 | 02:49h | UTCSee Original Guideline: Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19
Study Validates Loss of Smell and Taste as Symptoms of Covid-19
14 Apr, 2020 | 02:57h | UTC
Face Masks Against COVID-19: An Evidence Review
14 Apr, 2020 | 02:52h | UTCFace Masks Against COVID-19: An Evidence Review – Preprints
Related Analysis: Face Masks for the Public During the Covid-19 Crisis
Richard Lehman’s Covid-19 Reviews
14 Apr, 2020 | 02:46h | UTCRichard Lehman’s covid-19 reviews—13 April 2020 – The BMJ Opinion
“In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19.”
WHO Scientific Brief: BCG vaccination and COVID-19
14 Apr, 2020 | 02:47h | UTCBacille Calmette-Guérin (BCG) vaccination and COVID-19 – World Health Organization
Related Opinion: BCG Against Coronavirus: Less Hype and More Evidence, Please
“There is no evidence that the Bacille Calmette-Guérin vaccine (BCG) protects people against infection with COVID-19 virus.”
Systematic Review: Maternal and Perinatal Outcomes with COVID‐19
14 Apr, 2020 | 02:41h | UTC
IDSA Guidelines on the Treatment and Management of Patients with COVID-19 Infection
13 Apr, 2020 | 00:27h | UTC
Related Commentary on Twitter
NEW: IDSA Guidelines on the Treatment & Management of Patients with COVID-19 Infection. These evidence-based rapid guidelines, updated in real-time, will address pressing clinical questions related to caring for patients w/ COVID-19: https://t.co/mvi9Paa8Xv #COVID19Guidelines pic.twitter.com/NKbYAbO21J
— IDSA (@IDSAInfo) April 11, 2020
Systematic Review: Treatment of Depression in Children and Adolescents
14 Apr, 2020 | 02:34h | UTCTreatment of Depression in Children and Adolescents – Agency for Healthcare Research and Quality
See also: Full Report AND Executive Summary:
Implementation Guide: Optimizing Medication Management during the COVID-19 Pandemic
13 Apr, 2020 | 00:18h | UTC
Related Commentary on Twitter
Task force recommendations about managing meds in post-acute and long-term care during COVID-19. https://t.co/yoU76suVYo
Summary of recommendations in thread below:
— Mike Steinman (@MikeSteinman) April 10, 2020
Studies: Obesity Increases the Risk of Complications in Patients with Covid-19
13 Apr, 2020 | 00:14h | UTC2 – Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission – Clinical Infectious Diseases AND Commentary: In New York, obesity appears to raise COVID-19 risk – CIDRAP
Study: Antibody Tests Reveal 14% are Immune to Covid-19 in German Town
13 Apr, 2020 | 00:10h | UTC- Blood tests show 14% of people are now immune to covid-19 in one town in Germany – MIT Technology Review
- COVID antibody test in German town shows 15 percent infection rate – Spectator
- Expert reaction to unpublished preliminary findings looking at the presence of antibodies to SARS-CoV-2 virus in residents of Gangelt, in Germany – Science Media Centre
The original report can be found here (in German)
Studies: Diabetes Increases the Risk of Complications in Patients with Covid-19
13 Apr, 2020 | 00:12h | UTC1 – Prevalence and impact of diabetes among people infected with SARS-CoV-2 – Journal of Endocrinological Investigation AND Commentary: Diabetes Could Increase Severity of COVID-19, Including Risk of ICU Admission and Death – MedicalResearch.com
2 – Evidence Reviews: Diabetes and risks from COVID-19 – CEBM University of Oxford AND Managing diabetes during the COVID-19 pandemic – CEBM University of Oxford